Sanda, M G <br/><br/>
Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.  [electronic resource] 

 -  Urology  Feb 1999 
 - 260-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0090-4295 
<br/><br/><label>Standard No.: </label>10.1016/s0090-4295(98)00539-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--therapeutic use<br/>Antibodies--blood<br/>Cancer Vaccines--immunology<br/>Humans<br/>Male<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Vaccines, Synthetic--immunology